Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Omega-3 Questions Could Pull Plug On Sales Growth

Feb 19 2014

• By Emily Hayes

Related Content

DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up

May 21 2012

HPS2-THRIVE Post-Mortem: Lessons Learned For CV Drug Developers

Mar 18 2013

ANCHOR Indication For Amarin’s <em>Vascepa</em> Will Face FDA Panel Scrutiny

Jun 19 2013

Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims

Feb 03 2014

Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

Jan 24 2011

Cholesterol Guidelines Look High And Low: Statin Market Extended At Both Ends

Nov 13 2013

Cholesterol Drug Approvals May Hinge On Outcomes Studies; FDA Rejects Diabetes-style Tiered Trials

Oct 21 2013

FDA Makes It Formal, Rescinds SPA For Amarin’s ANCHOR Study

Oct 30 2013

Related Companies

GSK plc

Amarin Corp plc

Merck & Co., Inc.

Abbott

BASF AG

Royal DSM N.V.

Sanofi

Mochida Pharmaceutical Co., Ltd.

Additional Topics

United States Advertising, Marketing & Sales Business Strategies Manufacturing Drug Approval Standards Regulation Post Market Regulation & Studies Compliance Advisory Committees Clinical Trials OTC Drugs Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window